Metraipolis › archive › dc_8ffd41bb05a7

Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41831086
DOI
10.1007/s11892-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-04T18:33:27.999Z
SHA-256 of the archived text
d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c
Stable URL of this page
https://metraipolis.com/documento/dc_8ffd41bb05a7

How to cite

Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086 — Europe PMC (en), https://europepmc.org/article/MED/41831086 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8ffd41bb05a7 (Metraipolis archive dc_8ffd41bb05a7, sha256 d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c)
BibTeX
@misc{dc8ffd41bb05a7,
  title = {Pharmacologic Treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease in the Context of Type 2 Diabetes — Europe PMC PMID:41831086},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41831086},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8ffd41bb05a7; sha256 d57245afbb184ba4e40c6b281907c3adde6152d27f521a582fa62f348f83d32c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41831086. Agents can read the archived copy with the MCP tool read_document.